CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- 3 Insider Initial Statement of Ownership
- 4 Option exercise EVP & Chief Financial Officer acquired 6,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 1,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 3 of 34 · 664 filings